Related Experiment Videos
Mammographic screening under age 50: a review
1University Hospital Malmö, Malmö, Sweden.
Breast (Edinburgh, Scotland)
|January 21, 2004
Summary
Mammography screening for women aged 40-49 offers a clear mortality benefit. However, the decision to screen this age group involves weighing benefits against potential side-effects and costs.
Area of Science:
- Oncology
- Radiology
- Public Health
Background:
- Mammography is a key tool in breast cancer detection.
- Screening guidelines vary regarding the optimal age to initiate mammography.
Purpose of the Study:
- To evaluate the mortality benefit of mammography screening in women aged 40-49.
- To discuss the balance between screening benefits and harms.
Main Methods:
- Analysis of clinical trial data on mammography screening outcomes.
- Assessment of mortality reduction associated with screening.
Main Results:
- Mammography screening in women aged 40-49 demonstrates a significant reduction in mortality.
- The benefits must be weighed against potential harms and costs.
Conclusions:
- A clear mortality benefit exists for mammography screening in women aged 40-49.
- National health authorities consider this benefit sufficient to recommend general screening for this demographic.